Evidence map›Paper›PMID 42675588›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Ablation-Immune Thermal Armor Via Microstructural-Compatibility Design for Extreme Thermal Conditions.

Hongkang Ou, Lingxiang Guo, Bing Liu, Ziyi Yi, Yuyu Zhang, Jia Sun, Qiangang Fu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hongkang OuShaanxi Key Laboratory of Fiber Reinforced Light Composite Materials, Northwestern Polytechnical University, Xi'an, People's Republic of China.
Lingxiang GuoShaanxi Key Laboratory of Fiber Reinforced Light Composite Materials, Northwestern Polytechnical University, Xi'an, People's Republic of China.
Bing LiuShaanxi Key Laboratory of Fiber Reinforced Light Composite Materials, Northwestern Polytechnical University, Xi'an, People's Republic of China.
Ziyi YiShaanxi Key Laboratory of Fiber Reinforced Light Composite Materials, Northwestern Polytechnical University, Xi'an, People's Republic of China.
Yuyu ZhangShaanxi Key Laboratory of Fiber Reinforced Light Composite Materials, Northwestern Polytechnical University, Xi'an, People's Republic of China.
Jia SunShaanxi Key Laboratory of Fiber Reinforced Light Composite Materials, Northwestern Polytechnical University, Xi'an, People's Republic of China.ORCID https://orcid.org/0000-0002-5851-4018
Qiangang FuShaanxi Key Laboratory of Fiber Reinforced Light Composite Materials, Northwestern Polytechnical University, Xi'an, People's Republic of China.

Funding

National Defense Basic Scientific Research Program of China JCKY2022607C007National Defense Basic Scientific Research Program of China JCKYS20250106National Natural Science Foundation of China 52125203National Natural Science Foundation of China 52472107
6 · The paper itself

Abstract

To overcome the brittleness and microstructural degradation of ultrahigh temperature ceramics (UHTCs) in hypersonic thermal protection systems, this work develops a C/C-ZrC-SiC/ZrC-SiC composite via a microstructural-compatibility design that integrates reactive melt infiltration with supersonic atmospheric plasma spraying. Critically, this work strategically incorporated SiC as a dispersed phase in the ZrC coating to actively regulate the deposition thermodynamics and oxidation kinetics, which suppresses the formation of continuous, lamellar ZrO

Indexed as

ablation resistanceplasma sprayingthermal protectionultrahigh temperature ceramics

Identifiers

PMID42675588
PMCPMC13530017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.